PROGYNY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.53 USD | -15.29% |
|
-13.21% | -25.95% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Companyâs clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a memberâs full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Sector
Managed Healthcare
Calendar
23/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
27.53
USD
Average target price
40.67
USD
Spread / Average Target
+47.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -25.95% | 2.65B | |
| -2.59% | 472B | |
| +14.34% | 125B | |
| +16.34% | 98.97B | |
| +4.82% | 41.51B | |
| -26.70% | 40.44B | |
| -20.67% | 1.31B | |
| -13.87% | 407M |
- Stock Market
- Equities
- PGNY Stock
- News Progyny, Inc.
- KeyBanc Adjusts Progyny Price Target to $45 From $50, Maintains Overweight Rating